Starting Friday, Americans can order the nasal spray flu vaccine online and have it shipped directly to their home.

AstraZeneca introduces FluMist Home, offering a needle-free flu vaccine delivered directly to your door. This FDA-approved ...

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

AstraZeneca PLC released its flu vaccine nasal spray for at-home use on Friday, an option that comes at a contentious time ...

FluMist nasal spray can now be delivered directly to homes in 34 states, including Michigan, offering a new way to fight the ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

FluMist has been approved since 2003, but, until last year, only for administration by a healthcare practitioner. The new nod ...

AstraZeneca PLC closed 13.46% below its 52-week high of £133.88, which the company reached on September 3rd.

George Soros (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into ...

AstraZeneca has endorsed US President Donald Trump’s demands for pharmaceutical companies to lower prescription drug prices ...

AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...